查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493336

病患援助技術市場規模、佔有率、趨勢分析報告：按類型、地區、細分市場預測，2024-2030 年

Patient Support Technology Market Size, Share & Trends Analysis Report By Type (Standalone, Integrated), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

患者援助技術市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，全球患者援助技術市場預計到2030年將達到32億美元，2024年至2030年的複合年成長率為10.7%。

對以患者為中心的綜合解決方案的需求不斷成長、醫療保健系統擴大採用數位醫療保健解決方案、技術進步以及市場參與企業對策略進步的積極參與將推動市場成長。

此外，行動醫療應用程式或行動醫療應用程式在加速患者輔助技術市場的成長方面發揮著重要作用。這些應用程式提供各種功能，例如用藥提醒、健康監測、症狀追蹤和虛擬諮詢。這些應用程式允許患者積極參與醫療保健管理、促進健康習慣並促進與醫療保健提供者的無縫溝通，從而增強患者的能力。智慧型手機和穿戴式裝置使用的增加正在擴大行動行動醫療應用程式的採用，並鞏固其作為患者援助技術生態系統重要組成部分的地位。

根據 IQVIA 的說法，為相關人員尋求最佳結果的公司應將其患者支援計劃 (PSP) 技術投資策略與 EESI (EASY) 目標保持一致。這些目標的重點是加強與患者和護理合作夥伴的互動，促進服務團隊之間的協作，簡化使用者體驗，並增強洞察力的生成以改善患者的治療結果。這種協作包括患者和護理合作夥伴的積極參與、有效的溝通、促進共用決策、服務團隊之間的無縫團隊合作和溝通，以及提高可用性的直覺設計，其中包括設計介面和利用資料驅動的方法來獲得可操作的見解和簡化流程。透過將 PSP 技術投資策略與 EESI (EASY) 目標結合，公司可以提高病人參與、增強團隊合作、簡化使用者體驗並改善患者治療效果。

此外，技術還提供了增強項目績效衡量的潛力，並允許納入對患者結果的可行評估。該技術用於徹底調查長期治療結果並幫助評估長期治療期間的患者結果。此外，人工智慧和機器學習主導的技術平台可以分析患者的多樣化需求，並實現更客製化和個人化的體驗。將創新技術整合到患者支援生命週期的不同階段，為透過資料和進階分析全面了解患者需求提供了機會。

2023 年 9 月，微軟和 Mercy 合作，利用生成式人工智慧和數位技術，使醫療保健提供者能夠將更多時間花在患者照護上並改善患者體驗。人工智慧輔助的生成式溝通透過提供易於理解的測試結果並促進知情討論來增強患者的能力。此外，聊天機器人將幫助 Mercy 的同事快速存取他們所需的資訊，使護理師和工作人員能夠更專注於患者照護。

患者援助技術市場報告亮點

  • 按類型分類，由於提供全面的解決方案並專注於以患者為中心的護理，整合細分市場將在 2023 年佔據市場主導地位。
  • 2023年，北美地區將以41.12%的收益佔有率主導全球市場。這一成長是由政府舉措的不斷加強、醫療保健行業的技術進步以及主要市場參與者的強大影響力所推動的。
  • 患者輔助科技市場競爭激烈，各公司採取新產品推出、合作和收購等策略來增加市場佔有率。例如，2023 年 10 月，ZS 宣布推出人工智慧驅動的 ZAIDYN Connected Health 解決方案，該解決方案是 ZAIDYN by ZS 平台的一部分。 ZAIDYN Connected Health 幫助製藥公司、醫療保健提供者和付款人進行創新，以了解未滿足的需求、與患者建立更好的關係並改善健康結果。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章患者輔助科技市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 病人援助技術市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 的影響

第4章患者支持技術市場：類型估計和趨勢分析

  • 2023 年和 2030 年按類型分類的市場佔有率
  • 細分儀表板
  • 按類型分類的全球病患援助技術市場前景
  • 獨立的
  • 融合的

第5章患者支援技術市場：按類型分類的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Deloitte
    • Accenture
    • McKesson Corporation
    • Cardinal Health
    • DataRiver Srl
    • Medisafe
    • Inizio Engage
    • AssistRx
Product Code: GVR-4-68040-284-8

Patient Support Technology Market Growth & Trends:

The global patient support technology market is expected to reach USD 3.2 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing requirement for comprehensive patient-centric solutions, increasing adoption of digital healthcare solutions by healthcare systems, technological advancements, and active participation in strategic advancements by the market players are expected to drive market growth.

Furthermore, mobile health applications or mHealth apps are playing a crucial role in accelerating the growth of the patient support technology market. These applications provide diverse functionalities, including medication reminders, health monitoring, symptom tracking, and virtual consultations. They encourage patients by enabling active engagement in their healthcare management, promoting healthy habits, and facilitating seamless communication with healthcare providers. The rising use of smartphones and wearable devices amplifies the adoption of mHealth apps, solidifying their position as an essential component of the patient support technology ecosystem.

According to IQVIA, companies seeking optimal outcomes for stakeholders should align their investment strategy in Patient Support Program (PSP) technology with the EESI (EASY) goals. These objectives emphasize enhancing patient and care partner engagement, fostering collaboration among service teams, simplifying user experiences, and enhancing insight generation for improved patient outcomes. This alignment involves promoting active participation, effective communication, and shared decision-making among patients and their care partners, facilitating seamless teamwork and communication across service teams, designing intuitive interfaces for enhanced usability, and leveraging data-driven approaches to derive actionable insights and streamline workflows. By integrating their PSP technology investment strategy with the EESI (EASY) goals, companies can elevate patient engagement, enhance team collaboration, streamline user experiences, and drive better patient outcomes.

Furthermore, technology offers the potential to enhance program performance measurement, enabling the incorporation of practical assessments into patient outcomes. This technology is utilized to conduct thorough investigations into longitudinal performance, aiding in evaluating patient outcomes during therapy over extended periods. Furthermore, AI and machine learning-driven technology platforms analyze patients' diverse needs, enabling a more customized and personalized experience. Integrating innovative technologies across different stages of the patient support lifecycle presents an opportunity to gain comprehensive insights into patient needs through data and advanced analytics.

In September 2023, Microsoft Corp. and Mercy partnered to utilize generative AI and digital technologies, enabling healthcare providers to devote more time to patient care and enhance the patient experience. Generative AI-assisted communication empowers patients by providing understandable lab results and facilitating informed discussions. Additionally, the chatbot aids Mercy co-workers in swiftly accessing essential information, allowing nurses and staff to focus more on patient care.

Patient Support Technology Market Report Highlights:

  • Based on type, the integrated segment dominated the market in 2023, owing to the availability of a comprehensive solution and increased focus on patient-centered care.
  • North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players.
  • The patient support technology market is competitive, and various players are adopting strategies such as new product launches, partnerships, and acquisitions to strengthen their market share. For instance, in October 2023, ZS launched the AI-powered ZAIDYN Connected Health solution, part of the ZAIDYN by ZS platform. ZAIDYN Connected Health helps pharmaceutical companies, healthcare providers, and payers innovate to understand unmet needs, better engage with patients, and improve health outcomes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Patient Support Technology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Patient Support Technology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & legal landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social & environmental landscape
      • 3.3.2.4. Technological landscape
    • 3.3.3. Impact of COVID-19

Chapter 4. Patient Support Technology Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Patient Support Technology Market by Type Outlook
  • 4.4. Standalone
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Integrated
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Patient Support Technology Market: Regional Estimates & Trend Analysis, By Type

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. France
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Italy
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Spain
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Denmark
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Sweden
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework/ reimbursement structure
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Norway
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework/ reimbursement structure
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework/ reimbursement structure
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework/ reimbursement structure
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework/ reimbursement structure
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework/ reimbursement structure
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework/ reimbursement structure
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
    • 6.2.2. List of key distributors and channel partners
    • 6.2.3. Key customers
    • 6.2.4. Key company market share analysis, 2023
    • 6.2.5. Deloitte
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Accenture
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. McKesson Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Cardinal Health
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. DataRiver S.r.l
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Medisafe
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Inizio Engage
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. AssistRx
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 6 Europe patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 8 Germany patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 9 UK patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 10 France patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 11 Italy patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 12 Spain patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 13 Denmark patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 14 Sweden patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 15 Norway patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 18 China patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 19 Japan patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 20 India patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 21 South Korea patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 22 Australia patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 23 Thailand patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 24 Latin America patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 26 Brazil patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 29 MEA patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 31 South Africa patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait patient support technology market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Patient support technology market: market outlook
  • Fig. 9 Patient support technology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Patient support technology market driver impact
  • Fig. 15 Patient support technology market restraint impact
  • Fig. 16 Patient support technology market strategic initiatives analysis
  • Fig. 17 Patient support technology market: Type movement analysis
  • Fig. 18 Patient support technology market: Type outlook and key takeaways
  • Fig. 19 Standalone market estimates and forecast, 2018 - 2030
  • Fig. 20 Integrated market estimates and forecast, 2018 - 2030
  • Fig. 21 Global patient support technology market: Regional movement analysis
  • Fig. 22 Global patient support technology market: Regional outlook and key takeaways
  • Fig. 23 Global patient support technology market share and leading players
  • Fig. 24 North America market share and leading players
  • Fig. 25 Europe market share and leading players
  • Fig. 26 Asia Pacific market share and leading players
  • Fig. 27 Latin America market share and leading players
  • Fig. 28 Middle East & Africa market share and leading players
  • Fig. 29 North America: SWOT
  • Fig. 30 Europe SWOT
  • Fig. 31 Asia Pacific SWOT
  • Fig. 32 Latin America SWOT
  • Fig. 33 MEA SWOT
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S. key country dynamics
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030
  • Fig. 59 Japan key country dynamics
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 72 Mexico key country dynamics
  • Fig. 73 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina key country dynamics
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 77 South Africa key country dynamics
  • Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 79 Saudi Arabia key country dynamics
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 81 UAE key country dynamics
  • Fig. 82 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 83 Kuwait key country dynamics
  • Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 85 Key company categorization
  • Fig. 86 Company market position analysis, 2023
  • Fig. 87 Strategy mapping